Vaccination and herd immunity: what more do we know? : Current Opinion in Infectious Diseases

Secondary Logo

Journal Logo

PAEDIATRIC AND NEONATAL INFECTIONS: Edited by Paul T. Heath

Vaccination and herd immunity

what more do we know?

Rashid, Harunora; Khandaker, Gulama; Booy, Roberta,b

Author Information
Current Opinion in Infectious Diseases 25(3):p 243-249, June 2012. | DOI: 10.1097/QCO.0b013e328352f727

Abstract

Purpose of review 

This review summarizes herd immunity, focusing on conceptual developments with application to vaccination programs.

Recent findings 

The conventional idea of herd immunity is based on the relationship between the transmission dynamics of infectious agents and population immunity. However, there have been some recent conceptual developments in vaccine ‘herd immunity’ or ‘herd protection’ that address the complexities of imperfect immunity, heterogeneous populations, nonrandom vaccine uptake and ‘freeloaders’. Some vaccines may provide better protection than others; for instance, meningococcal conjugate vaccines are superior to polysaccharide vaccines, as is true of pneumococcal and Haemophilus influenzae type b vaccines. Achieving a very high uptake rate should be the target for certain vaccines, for example, measles vaccine, in order to prevent the disease effectively. Emerging issues, for example, waning of immunity after pertussis vaccination, are fresh challenges.

Summary 

Herd immunity is a complex issue inherent to a vaccine and the population receiving the vaccine. We have more to learn and apply.

© 2012 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid